Shares in Novo Nordisk fell as much as 30% after it slashed sales and profits forecasts for the second time this year amid pressure from rival Eli Lilly.Read More

You might also be interested in reading MetaMask briefly pulled from App Store, British MPs argue for caution with NFT copyright infringement: Nifty Newsletter, Oct. 11–Oct. 17.